Figure 3
From: Baicalin target protein, Annexin A2, is a target of new antitumor drugs
The mRNA levels of STAT-3 (a), cIAP-1 (b), and cIAP-2 (c) in HepG2 cells treated with baicalin for 48 h were determined by RT-qPCR. The experiments were performed in quintuplicate. (d) The caspase-3 activity in HepG2 cells treated with baicalin for 48 h was measured with a Caspase-3 Activity Assay Kit. The experiments were performed in quadruplicate. The data are shown as the mean ± SD.
